{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T04:07:22Z","timestamp":1773115642062,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejinme.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.ejim.2017.06.022","type":"journal-article","created":{"date-parts":[[2017,7,3]],"date-time":"2017-07-03T09:48:53Z","timestamp":1499075333000},"page":"44-48","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Thrombophilic and cardiovascular risk factors for retinal vein occlusion"],"prefix":"10.1016","volume":"44","author":[{"given":"Paolo","family":"Bucciarelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serena M.","family":"Passamonti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Gianniello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Artoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ida","family":"Martinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2017.06.022_bb0005","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1056\/NEJMcp1003934","article-title":"Retinal-vein occlusion","volume":"363","author":"Wong","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2017.06.022_bb0010","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1111\/j.1538-7836.2010.03909.x","article-title":"Retinal vein thrombosis: pathogenesis and management","volume":"8","author":"Rehak","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ejim.2017.06.022_bb0015","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/jth.12982","article-title":"Prevalence and risk factors of retinal vein occlusion: the Gutenberg Health Study","volume":"13","author":"Ponto","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ejim.2017.06.022_bb0020","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S0002-9394(14)71345-5","article-title":"Risk factors for branch retinal vein occlusion","volume":"116","author":"The Eye-disease case-control study group","year":"1996","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ejim.2017.06.022_bb0025","first-page":"545","article-title":"Risk factors for central retinal vein occlusion","volume":"114","author":"The Eye-disease case-control study group","year":"1996","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ejim.2017.06.022_bb0030","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1001\/archopht.1996.01100140443012","article-title":"Prevalence and associations of retinal vein occlusion in Australia. The Blue Mountain Eye study","volume":"114","author":"Mitchell","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ejim.2017.06.022_bb0035","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.ophtha.2004.10.039","article-title":"Cardiovascular risk factors for retinal vein occlusion and arteriolar emboli: the Atherosclerosis Risk in Communities and Cardiovascular Health studies","volume":"112","author":"Wong","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ejim.2017.06.022_bb0040","doi-asserted-by":"crossref","first-page":"4297","DOI":"10.1167\/iovs.08-1826","article-title":"Traditional and novel cardiovascular risk factors for retinal vein occlusion: the Multi-Ethnic Study of Atherosclerosis","volume":"49","author":"Cheung","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ejim.2017.06.022_bb0045","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1159\/000073587","article-title":"Retinal vein thrombosis: risk factors, pathogenesis and therapeutic approach","volume":"32","author":"Prisco","year":"2002","journal-title":"Pathophysiol Haemost Thromb"},{"key":"10.1016\/j.ejim.2017.06.022_bb0050","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0953-6205(02)00025-0","article-title":"Cardiovascular and thrombophilic risk factors for central retinal vein occlusion","volume":"13","author":"Prisco","year":"2002","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ejim.2017.06.022_bb0055","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1055\/s-0037-1616130","article-title":"Thrombophilic risk factors in patients with central retinal vein occlusion","volume":"86","author":"Marcucci","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ejim.2017.06.022_bb0060","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0161-6420(01)00842-9","article-title":"Laboratory evaluation of hypercoagulable states in patients with central retinal vein occlusion who are less than 56 years of age","volume":"109","author":"Lahey","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ejim.2017.06.022_bb0065","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0002-9394(99)00074-4","article-title":"Retinal vascular occlusion and deficiencies in the protein C pathway","volume":"128","author":"Greiner","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ejim.2017.06.022_bb0070","first-page":"2437","article-title":"Antiphospholipid antibodies: a risk factor for occlusive retinal vascular disorders. Comparison with ocular inflammatory diseases","volume":"28","author":"Carbone","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ejim.2017.06.022_bb0075","first-page":"212","article-title":"Prevalence of factor V Leiden in young adults with retinal vein occlusion","volume":"77","author":"Linna","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ejim.2017.06.022_bb0080","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/00001721-199810000-00008","article-title":"Analysis of genetic polymorphisms related to thrombosis and other risk factors in patients with retinal vein occlusion","volume":"9","author":"Salomon","year":"1998","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.ejim.2017.06.022_bb0085","first-page":"702","article-title":"Retinal vein occlusion and inherited conditions predisposing to thrombophilia","volume":"80","author":"Albisinni","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ejim.2017.06.022_bb0090","first-page":"299","article-title":"MTHFR C677T mutation, factor II G20210A mutation and factor V Leiden as risk factors for youth retinal vein occlusion","volume":"154","author":"Cruciani","year":"2003","journal-title":"Clin Ther"},{"key":"10.1016\/j.ejim.2017.06.022_bb0095","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1177\/1076029614522544","article-title":"Thrombophilic mutations as risk factor for retinal vein occlusion: a case-control study","volume":"21","author":"Dello Russo","year":"2015","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.ejim.2017.06.022_bb0100","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1016\/j.ophtha.2009.02.033","article-title":"Homocysteine, methylenetetrahydrofolate reductase C677T polymorphism, and risk of retinal vein occlusion: a meta-analysis","volume":"116","author":"McGimpsey","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ejim.2017.06.022_bb0105","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1477-9560-3-13","article-title":"Homocysteine, MTHFR C677T gene polymorphism, folic acid and vitamin B12 in patients with retinal vein occlusion","volume":"3","author":"Terrazzi","year":"2005","journal-title":"Thromb J"},{"key":"10.1016\/j.ejim.2017.06.022_bb0110","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ajo.2004.06.084","article-title":"Homocysteine and retinal vein occlusion: a population-based study","volume":"139","author":"Chua","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ejim.2017.06.022_bb0115","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1160\/TH04-11-0768","article-title":"Retinal vein occlusion: a form of venous thrombosis or a complication of atherosclerosis? A meta-analysis of thrombophilic factors","volume":"93","author":"Janssen","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ejim.2017.06.022_bb0120","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1136\/bjo.73.9.693","article-title":"Medical conditions underlying retinal vein occlusion in patients with glaucoma or ocular hypertension","volume":"73","author":"Cole","year":"1989","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ejim.2017.06.022_bb0125","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1093\/oxfordjournals.aje.a008713","article-title":"A validated questionnaire for the identification of previous personal or familial venous thromboembolism","volume":"143","author":"Frezzato","year":"1996","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ejim.2017.06.022_bb0130","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1111\/j.1538-7836.2012.04858.x","article-title":"Low borderline plasma levels of antithrombin, protein C and protein S are risk factors for venous thromboembolism","volume":"10","author":"Bucciarelli","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ejim.2017.06.022_bb0135","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ejim.2017.06.022_bb0140","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0049-3848(97)00013-3","article-title":"Absence of hyperhomocysteinemia in ten patients with primary pulmonary hypertension","volume":"85","author":"Zighetti","year":"1997","journal-title":"Thromb Res"},{"key":"10.1016\/j.ejim.2017.06.022_bb0145","series-title":"Laboratory techniques in thrombosis. A manual","first-page":"107","article-title":"Tripodi A. Factor VIII clotting activity","author":"Mannucci","year":"1999"},{"key":"10.1016\/j.ejim.2017.06.022_bb0150","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0002-9394(00)00709-1","article-title":"Systemic diseases associated with various types of retinal vein occlusion","volume":"131","author":"Hayreh","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ejim.2017.06.022_bb0155","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/qjmed\/hcv088","article-title":"The role of coagulation disorders in patients with retinal vein occlusion","volume":"109","author":"Napal","year":"2016","journal-title":"QJM"},{"key":"10.1016\/j.ejim.2017.06.022_bb0160","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.thromres.2015.01.001","article-title":"Risk factors for idiopathic sudden sensorineural hearing loss and their association with clinical outcome","volume":"135","author":"Passamonti","year":"2015","journal-title":"Thromb Res"},{"key":"10.1016\/j.ejim.2017.06.022_bb0165","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/aos.13214","article-title":"No evidence for thrombophilia in patients with retinal vein occlusion: a systematic GRADE-based review","volume":"95","author":"Kirkegaard","year":"2017","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.ejim.2017.06.022_bb0170","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1136\/bjo.2008.151605","article-title":"Retinal vein occlusion and the risk of acute myocardial infarction: a 3-year follow-up study","volume":"93","author":"Hu","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ejim.2017.06.022_bb0175","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ajo.2008.08.006","article-title":"Retinal vein occlusion and the risk of stroke development: a five year follow-up study","volume":"147","author":"Ho","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ejim.2017.06.022_bb0180","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.ophtha.2013.07.025","article-title":"Mortality in patients with central retinal vein occlusion","volume":"121","author":"Bertelsen","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ejim.2017.06.022_bb0185","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1160\/TH07-04-0247","article-title":"Role of haemorheological factors in patients with retinal vein occlusion","volume":"98","author":"Sofi","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ejim.2017.06.022_bb0190","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.atherosclerosis.2009.11.006","article-title":"High lipoprotein(a) levels are associated with an increased risk of retinal vein occlusion","volume":"210","author":"Sofi","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejim.2017.06.022_bb0195","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/aos.13228","article-title":"Elevated lipoprotein(a) levels are an independent risk factor for retinal vein occlusion","volume":"95","author":"Kuhli-Hattenbach","year":"2017","journal-title":"Acta Ophthalmol"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620517302662?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620517302662?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,28]],"date-time":"2019-09-28T03:32:17Z","timestamp":1569641537000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620517302662"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":39,"alternative-id":["S0953620517302662"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2017.06.022","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thrombophilic and cardiovascular risk factors for retinal vein occlusion","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2017.06.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}